Clinical Trial Update: Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy of lapaquistat acetate in subjects with hypercholesterolemia. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 2 | Status: TERMINATED